Global Oligonucleotide Market Growth 2025-2031
The global Oligonucleotide market size is predicted to grow from US$ 1494 million in 2025 to US$ 2716 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
LP Information, Inc. (LPI) ' newest research report, the “Oligonucleotide Industry Forecast” looks at past sales and reviews total world Oligonucleotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide sales for 2025 through 2031. With Oligonucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DNA
RNA
Segmentation by Application:
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Oligo Factory
Danaher
Thermo Fisher Scientific
GE
Merck
Eurofins Scientific
Agilent
SUMITOMO CHEMICAL
Bachem
Sylentis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oligonucleotide market?
What factors are driving Oligonucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide market opportunities vary by end market size?
How does Oligonucleotide break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.